Cell Sorting Market - 2022

November 2025 | 243 pages | ID: C0F4E5A2059EEN
DataM Intelligence

Abstracts

The Cell Sorting Market was valued at USD 236.5 million in 2022 and is anticipated to reach by , at a CAGR of 0.066 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Cell Sorting Market.

This report delivers a comprehensive overview of the Cell Sorting Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Sorting Market. The Cell Sorting Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–.

Cell Sorting Market Scope:

By Technology

• Fluorescence-activated cell sorting (FACS)
• Magnetic-activated cell sorting (MACS)
• Micro-Electromechanical Systems (MEMS) Microfluidics
• Density Gradient Centrifugation
• Immunodensity Cell Separation
• Sedimentation
• Others

By Product and Services

• Cell Sorters
• Cell Sorting Reagents & Consumables
• Cell Sorting Services

By Application

• Clinical Applications
• Research Applications

By End user

• Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals and Clinical Testing Laboratories
• Medical Schools and Academic Institutions

Key Players

• Bio-Rad Laboratories, Inc.
• Sony Biotechnology Inc.
• BD
• Merck KGaA
• Danaher Corporation
• Miltenyi Biotec GmbH
• Affymetrix, Inc
• Sysmex Partec GmbH
• On-Chip Biotechnologies Co., Ltd.
• Thermo Fisher Scientific(LIST NOT EXHAUSTIVE)

Major Highlights

This report delivers a comprehensive overview of the Cell Sorting Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Sorting Market. The Cell Sorting Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Technology
3.2. Snippet by Product and Services
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing number of chronic disease testing
  4.1.2. Restraints
    4.1.2.1. High costs and services
  4.1.3. Opportunity
    4.1.3.1. Technological advancements
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Scenario Before COVID-19
  6.1.2. Scenario During COVID-19
  6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion

7. RUSSIA-UKRAINE WAR ANALYSIS

8. ARTIFICIAL INTELLIGENCE ANALYSIS

9. BY TECHNOLOGY

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.1.2. Market Attractiveness Index, By Technology
9.2. Fluorescence-activated cell sorting (FACS)*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Magnetic-activated cell sorting (MACS)
9.4. Micro-Electromechanical Systems (MEMS) Microfluidics
9.5. Density Gradient Centrifugation
9.6. Immunodensity Cell Separation
9.7. Sedimentation
9.8. Others

10. BY PRODUCT AND SERVICES

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
  10.1.2. Market Attractiveness Index, By Product and Services
10.2. Cell Sorters*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cell Sorting Reagents & Consumables
10.4. Cell Sorting Services

11. BY APPLICATION

11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2. Market Attractiveness Index, By Application
11.1. Clinical Applications*
  11.1.1. Introduction
  11.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.2. Research Applications
  11.2.1. Immunology & Cancer Research
  11.2.2. Stem Cell Research
  11.2.3. Drug Discovery
  11.2.4. Other Research Applications

12. BY END USER

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  12.1.2. Market Attractiveness Index, By End user
12.2. Research Institutes*
  12.2.1. Introduction
  12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Pharmaceutical & Biotechnology Companies
12.4. Hospitals and Clinical Testing Laboratories
12.5. Medical Schools and Academic Institutions

13. BY REGION

13.1. Introduction
  13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  13.1.2. Market Attractiveness Index, By Region
13.2. North America
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.2.7.1. The U.S.
    13.2.7.2. Canada
    13.2.7.3. Mexico
13.3. Europe
  13.3.1. Introduction
  13.3.2. Key Region-Specific Dynamics
  13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
  13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.3.7.1. Germany
    13.3.7.2. The U.K.
    13.3.7.3. France
    13.3.7.4. Italy
    13.3.7.5. Spain
    13.3.7.6. Rest of Europe
13.4. South America
  13.4.1. Introduction
  13.4.2. Key Region-Specific Dynamics
  13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
  13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.4.7.1. Brazil
    13.4.7.2. Argentina
    13.4.7.3. Rest of South America
13.5. Asia-Pacific
  13.5.1. Introduction
  13.5.2. Key Region-Specific Dynamics
  13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
  13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.5.7.1. China
    13.5.7.2. India
    13.5.7.3. Japan
    13.5.7.4. Australia
    13.5.7.5. Rest of Asia-Pacific
13.6. Middle East and Africa
  13.6.1. Introduction
  13.6.2. Key Region-Specific Dynamics
  13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
  13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user

14. COMPETITIVE LANDSCAPE

14.1. Competitive Scenario
14.2. Product Benchmarking
14.3. Company Share Analysis
14.4. Key Developments and Strategies

15. COMPANY PROFILES

15.1. Bio-Rad Laboratories, Inc.*
  15.1.1. Company Overview
  15.1.2. Product Portfolio and Description
  15.1.3. Financial Overview
  15.1.4. Key Developments
15.2. Sony Biotechnology Inc.
15.3. BD
15.4. Merck KGaA
15.5. Danaher Corporation
15.6. Miltenyi Biotec GmbH
15.7. Affymetrix, Inc
15.8. Sysmex Partec GmbH
15.9. On-Chip Biotechnologies Co., Ltd.
15.10. Thermo Fisher Scientific(*LIST NOT EXHAUSTIVE)

16. APPENDIX

16.1. About Us and Services
16.2. Contact Us